Medicine
Tivdak 40 mg/4 mL powder for injection
Tivdak 40 mg/4 mL powder for injection is a prescription medicine containing Tisotumab vedotin for intravenous use, marketed by Seagen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store TIVDAK vials refrigerated at 2ºC to 8ºC (36ºF to 46ºF) in the original…
Key facts
- Active ingredient (INN)
- Tisotumab vedotin
- Brand
- Tivdak
- Strength
- 40 mg/4 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Seagen
- Manufacturer
- Seagen
- Origin register
- US FDA, United States
- Storage
- Store TIVDAK vials refrigerated at 2ºC to 8ºC (36ºF to 46ºF) in the original carton to protect from light. Do not freeze. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01FX23 Tisotumab vedotin
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 September 2021
- Identifiers
- RxCUI 2571099, 2571104DailyMed set ID c9fe3f32-4219-466e-acb9-3f609b4f4df1NDC 51144-003Application BLA761208
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 4 mL in 1 vial | 51144-003-01 | Seagen | 20 September 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Tisotumab vedotin is a prescription medicine indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. It is available as powder for injection for intravenous use. MedsAcross supplies Tisotumab vedotin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Tisotumab vedotinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TIVDAK prescribing information (Seagen) · U.S. National Library of Medicine, DailyMed
- Tivdak: European public assessment report (EPAR) · European Medicines Agency
Need Tivdak 40 mg/4 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.